Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genmab announces positive results for sclerosis drug candidate
Reuters
Thursday, October 10, 2013 - 6:19pm
tags:
Genmab, MS, multiple sclerosis, ofatumumab
Janssen Purchase Doesn't Change Case For Idenix
Seeking Alpha
Thursday, October 10, 2013 - 6:17pm
tags:
Janssen, Idenix, IDX719
Antares' Otrexup Ready For FDA Approval
Seeking Alpha
Thursday, October 10, 2013 - 11:55am
tags:
Otrexup, FDA, rheumatoid arthritis, Antares, devices
Google visionaries ready to invest a fortune in revolutionizing aging process
Fierce Biotech
Thursday, October 10, 2013 - 11:31am
tags:
Google, Calico, aging
Is There a Biotech Bubble?
Barron's
Thursday, October 10, 2013 - 11:27am
tags:
biotech
Quest Diagnostics says third-quarter profit to miss estimates
Reuters
Thursday, October 10, 2013 - 11:21am
tags:
Quest Diagnostics, diagnostics
Why Did This Big Pharma Outperform Its Industry Peers?
Motley Fool
Thursday, October 10, 2013 - 11:19am
tags:
Pfizer
Express Scripts stops covering key Big Pharma drugs on cost-effectiveness grounds
Fierce Pharma
Thursday, October 10, 2013 - 10:01am
tags:
Express Scripts, Pfizer, Xeljanz, PBMs, JNJ, Stelara, GSK, Breo Ellipta
Understanding the Complex Challenges Facing AstraZeneca
Motley Fool
Thursday, October 10, 2013 - 9:58am
tags:
AstraZeneca, GSK, Merck, Pfizer
Study: Boston Scientific CRM batteries beat Medtronic, St. Jude
Mass Device
Thursday, October 10, 2013 - 9:47am
tags:
Boston Scientific, Medtronic, CRM batteries, St. Jude Medical, devices, implanted defibrillators
Dynavax Initiates Phase 1 Trial In Its Asthma Program
Seeking Alpha
Thursday, October 10, 2013 - 9:27am
tags:
Dynavax Technologies, asthma, AstraZeneca, AZD1419, toll-like Receptor (TLR) 9 agonist
Lundbeck, Otsuka start trials for Alzheimer's drug
Reuters
Thursday, October 10, 2013 - 8:31am
tags:
Otsuka, Lundbeck, Alzheimer's disease, Lu AE58054
Drug Billionaire Seeks Deals as Rivals Founder: Corporate India
Bloomberg
Thursday, October 10, 2013 - 8:24am
tags:
India, Sun Pharma, M&A
Teva Pharmaceutical plans to cut 5,000 employees as part of global restructuring plan
Yahoo/AP
Thursday, October 10, 2013 - 8:18am
tags:
Teva, layoffs, restructuring
Gilead Stops Leukemia Drug Trial Early on Patient Benefit
Bloomberg
Thursday, October 10, 2013 - 8:13am
tags:
Gilead Sciences, Idelalisib, Rituxan, chronic lymphocytic leukemia
Insight: Big Pharma braces for retirement of favorite regulator
Reuters
Thursday, October 10, 2013 - 8:12am
tags:
FDA, Big Pharma, Janet Woodcock
Johnson & Johnson poised to report solid Q3 results, says Bernstein
The Fly on the Wall
Thursday, October 10, 2013 - 8:11am
tags:
JNJ, earnings
7 Disruptive Drugs for the Next Decade
Motley Fool
Wednesday, October 9, 2013 - 10:42pm
tags:
Tecfidera, Biogen Idec, Bristol-Myers Squibb, Eliquis, Pfizer, Roche, Kadcyla, Immunogen, sofosbuvir, Gilead, ibrutinib, Pharmacyclics, Sarepta, eteplirsen, LX4211, Lexicon Pharmaceuticals
Vivus says drug delayed progression to diabetes
Yahoo/AP
Wednesday, October 9, 2013 - 10:39pm
tags:
Vivus, diabetes, Qsymia
Ariad Pharmaceuticals Plummets 70% as Drug Trial Held
Barron's
Wednesday, October 9, 2013 - 4:00pm
tags:
Ariad Pharmaceuticals, Iclusig, CML

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.